Cell type vulnerability refers to the selective susceptibility of specific neuronal and glial cell populations to tau pathology in each 4R-tauopathy. While all 4R-tauopathies share the accumulation of four-repeat tau isoforms, the pattern of affected cell types differs substantially between Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Argyrophilic Grain Disease (AGD), Globular Glial Tauopathy (GGT), and FTDP-17. Understanding these patterns provides insight into disease mechanisms, informs biomarker development, and reveals potential therapeutic targets. [1]
The selective vulnerability of specific cell types is a hallmark of neurodegenerative diseases. In 4R-tauopathies, different diseases show distinct patterns of neuronal and glial involvement, reflecting differences in: [2]
This page synthesizes current knowledge of cell type vulnerability across all 4R-tauopathies, identifying shared and unique features. [3]
PSP demonstrates characteristic neuronal vulnerability: [4]
Primary affected neurons:
Vulnerability pattern: PSP shows predominant subcortical involvement with particular sensitivity of GABAergic pallidal neurons. The pattern correlates with the characteristic vertical gaze palsy and postural instability.
CBD shows a different pattern of neuronal vulnerability:
Primary affected neurons:
Vulnerability pattern: CBD demonstrates asymmetric cortical involvement with prominent basal ganglia pathology. The "cortical" and "basal" components reflect involvement of both cortical and subcortical neuronal populations.
AGD shows a limbic-predominant pattern:
Primary affected neurons:
Vulnerability pattern: AGD preferentially affects the limbic system, which correlates with the prominent memory and behavioral symptoms. The "grains" are primarily located in neuronal dendrites.
GGT is unique among 4R-tauopathies in showing predominant glial involvement:
Primary affected cells:
Vulnerability pattern: GGT represents a "gliopathy" rather than a primary neuronopathy, with globular inclusions in glia being the defining feature.
FTDP-17 shows mutation-dependent neuronal vulnerability:
Primary affected neurons:
Vulnerability pattern: Different MAPT mutations produce different patterns of neuronal loss, providing insight into how tau dysfunction leads to selective vulnerability.
PSP: tufted astrocytes — tau inclusions in proximal astrocytic processes
CBD: astrocytic plaques — diffuse tau in astrocytic cytoplasm
AGD: less prominent astrocytic involvement
GGT: globular astroglial inclusions (GAIs) — spherical tau accumulations
PSP: coiled bodies in white matter
CBD: less prominent oligodendroglial involvement
AGD: coiled bodies, often prominent
GGT: globular oligodendroglial inclusions (GOIs) — the defining feature
All 4R-tauopathies show microglial activation, but the pattern varies:
| Disease | Primary Neuronal Vulnerability | Primary Glial Vulnerability | Unique Feature |
|---|---|---|---|
| PSP | GPi, SNc, pontine nuclei | Tufted astrocytes | Subcortical predominance |
| CBD | Cortical layer 5, striatal | Astrocytic plaques | Asymmetric cortical |
| AGD | Hippocampal CA2/3, entorhinal | Coiled bodies | Limbic predominance |
| GGT | Minimal neuronal | GOIs, GAIs | Primary gliopathy |
| FTDP-17 | Variable by mutation | Variable | Mutation-specific |
The pattern of cell type vulnerability in 4R-tauopathies supports prion-like spreading:
Cell type-specific markers could serve as biomarkers:
Dickson et al. Neuropathology of 4R-tauopathies. Acta Neuropathol. 2022. 2022. ↩︎
Kovacs et al. Cell type-specific tau pathology in 4R-tauopathies. Brain. 2023. 2023. ↩︎
Lowe et al. Globular glial tauopathy: a novel 4R-tauopathy. J Neuropathol Exp Neurol. 2021. 2021. ↩︎
Williams et al. Astrocytic pathology in 4R-tauopathies. Acta Neuropathol Commun. 2024. 2024. ↩︎